Uncategorized

Inaugural Acuity Brands deal prices well behind peer

admin | October 30, 2020

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

The new issue market produced a few inaugural deals the last week of October, including a 10-year bond for Acuity Brands (AYI). The proceeds of the new $500 million issue are to be used to repay the company’s existing $400 million term loan maturing 2023, with the remainder earmarked for general corporate purposes, adding some incremental debt to the company’s very strong balance sheet. Despite the additional debt, the new deal is positive for the credit as it extends the company’s maturity profile by seven years. The AYI is trading roughly 40 bp behind similarly rated peer IDEX Corp, despite boasting stronger credit and liquidity profiles. The trading differential between AYI 2.15% 12/15/30 bonds and IEX 3.0% 5/1/30 bonds is too wide and should collapse closer to 20 bp.

Given the size of the issue and the fact that it’s the only bond outstanding for the company, the deal was priced attractively relative to peers to garner interest. Even after the additional $100 million of debt, AYI remains in net cash position, that coupled with its free cash flow generation provides for solid financial flexibility to navigate the slowdown in the non-residential construction market since the pandemic started. It’s reasonable that IDEX Corp. (IEX – Baa2/BBB/BBB+) should trade through AYI as its end market diversification helps to limit cyclicality and provide for more stable revenue generation.

Exhibit 1: AYI vs. IEX Financial and Credit Profile Comparison

Note: *Total debt pro forma new issue.
Source: Company Reports, Bloomberg TRACE, Amherst Pierpont Securities
Lighting the Way in UV Disinfection Solutions

AYI is largely a lighting manufacturer that serves the commercial, institutional and infrastructure markets with both indoor and outdoor lighting and building management solutions. AYI maintains a portfolio of UV disinfection products and recently signed strategic agreements with Violet Defense LLC and Puro Lighting to expand upon this product portfolio. The agreements allow for AYI and PURO to use Violet Defense’s patented UV technology, in coming up with much needed and in demand UV disinfection lighting solutions for the post COVID world. AYI is looking at the partnerships to drive long-term solutions in an effort to create the most impactful technologies rather than as short –term market opportunity. As commercial buildings address the health and safety of its occupants, the solution will likely be some combination of UV disinfection lighting, IP and control technologies coupled with building management, all areas that AYI has made significant investments. The opportunity for these types of solutions has been rumored to be in the multi-billion range and AYI believes they are positioned to take a disproportionate share.

COVID-Era Renovations a Bright Spot

While new construction indicators remain weak, management noted that larger projects have come back online while smaller/medium sized construction projects continue to remain on hold. While these projects continue to be in a holding pattern, management said they have not seen any cancellations yet but would argue that some could get canceled should a second wave of the virus hit in a meaningful way. Importantly for AYI, their revenue mix is roughly 50% new construction and 50% renovation. The renovation market will likely continue to be a bright spot in 2021, a trend that AYI has witnessed for the past couple of years. Management is confident that they will see real opportunities in the renovation market particularly for hospitals, office spaces, restaurants, and the hospitality industry, both in UV disinfection lighting technology as well as more traditional renovation surrounding energy savings. Additionally, AYI noted they have seen an uptick in residential renovations as people have more time for do-it-yourself lighting projects given the shelter in place orders.

Margins Remains Largely Intact

Gross margin for fiscal 4Q was flat year-over-year at 42.1%, despite a 5% decline in revenues during the quarter. For the full fiscal year, AYI was able to expand the gross margin nearly 200 bp (to 42.2%), in the face of a 9% revenue decline. Management noted that economic pressure created by the pandemic led to oversupply in the market. AYI felt the prudent way to manage inventory supply was to make strategic investments in price versus a blanket type approach that many of their competitors took. This led to the maintenance/expansion of the gross margin while making market share gains. The adjusted EBITDA margin for the year totaled 14.9%, down only 30 bp year-over-year as SG&A expenses were relatively flat. For the past three fiscal years, AYI’s average adjusted EBITDA margin was 15.0%. Additionally, consensus estimates are calling for AYI to post an EBITDA margin of 14.7% for fiscal 2021, a 20 bp decline. While IEX has a much stronger margin profile, consensus estimates have IEX ending the year with and EBITDA margin of 25.9%, translating to a 230 bp decline year-over-year.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.